The Japan NTD Tracker summarizes the amount of money Japan is spending to contribute to global NTD measures.
summary
- The total contribution amount for 2010-2019 is more than 15 billion yen.
- Investment in pharmaceutical R & D by the GHIT Fund accounts for the majority of expenditures from Japan.
- Japan's spending is concentrated in research areas. Expenditures in non-research fields are limited to a small part such as technical cooperation by JICA and contributions to ESPEN.
- Technical cooperation by JICA has been tapering off, and in recent years, the focus has shifted to research cooperation by SATREPS.
The details of the organizations and programs monitored by Japan NTD Tracker are as follows. In addition to those listed here, domestic research institutes are conducting a number of NTDs-related research with government research grants, but they are omitted.
Japan International Cooperation Agency (JICA)
An independent administrative agency under the jurisdiction of the Ministry of Foreign Affairs, which is the implementing agency for Japan's Official Development Assistance. We are engaged in various cooperation projects for the socio-economic development of developing countries.
Among the technical cooperation by JICA (projects with a total amount of 200 million yen or more, SATREPS projects excluded), grant aid, and grassroots technical cooperation projects, the projects implemented after 2010 with the main purpose of NTDs countermeasures are posted. .. Since 2010, no loan aid projects related to NTDs have been identified.
Since JICA does not disclose the budget amount for each year, the total project cost shown in the evaluation at the end of each project or the preliminary evaluation report is divided equally by the project period (months) and allocated to each year. .. In addition, the total project cost shown in the preliminary evaluation report is an approximate amount and may differ from the actual amount.
JICA's operation and management costs are not included.
It is thought that JICA's Japan Overseas Cooperation Volunteers dispatch, private sector cooperation, and technical cooperation projects with a total amount of less than 200 million yen also include projects related to NTDs, but there is no database that can confirm the amount of cooperation. Therefore, it is omitted here.
Global Health Innovative Technology Fund (GHIT Fund)
A public interest corporation jointly funded by the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labor and Welfare), Japanese pharmaceutical companies, the Bill & Melinda Gates Foundation, and Wellcome Trust. Invested in drug research and development for malaria, tuberculosis and NTDs from 2013.
Shows the total amount invested by the GHIT Fund in NTDs drug, vaccine and diagnostic R & D projects (35 projects in total by December 2020).
GHIT Fund operation and management costs are not included.
Projects are typically implemented over multiple years, but the table above assigns the total investment in each project to the year of receipt.
Contributions from the Government of Japan go through the United Nations Development Program (UNDP), part of which is devoted to the operation of the Access and Delivery Partnership (ADP). However, it is not included in the above table.
"International Joint Research Program for NTDs Countermeasures in Africa" by Japan Agency for Medical Research and Development (AMED)
AMED is a national research and development corporation under the jurisdiction of the Cabinet Office, Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labor and Welfare, and Ministry of Economy, Trade and Industry, and was established in 2015. Of the many medical research support programs undertaken by AMED, only the amount subsidized by the "International Joint Research Program for NTDs Countermeasures in Africa" is included here. The program was created in response to the 2015 Global Research Council, when Prime Minister Abe (then) announced that he would launch an international collaborative research focused on African NTDs. Grant from the Ministry of Education, Culture, Sports, Science and Technology for the purpose of developing preventive, diagnostic, drug discovery, and therapeutic methods for NTDs, aiming for social implementation of results, and developing human resources for young researchers in Africa through joint research. It is operated in.
By the end of 2020, the program has adopted four research projects (three in 2015-2019 and one in 2018-2021).
The table above shows the amount allocated to each project by year.
AMED operation and management costs are not included.
In addition to this program, AMED has programs used for research related to NTDs, but they are omitted here.
Science and Technology Research Partnership for Sustainable Development (SATREPS)
SATREPS is a project of the Japanese government that promotes joint research with developing countries with the aim of solving global issues. The field of infectious diseases of SATREPS was originally operated jointly by the Japan Agency for Medical Research and Development (JST) and JICA, but in 2015 it was transferred to the joint operation of AMED and JICA. Here, the amount of Japanese cooperation in a research project that includes NTDs in the field of SATREPS infectious diseases after transfer is included.
The table above lists the amount of subsidies for NTDs-related projects among the SATREPS projects implemented after the transfer of AMED.
Some projects are also studying diseases other than NTDs, but here the total amount of the project is recorded as the amount of contribution to NTDs.
Regarding the SATREPS business before the establishment of AMED, the amount before 2014 is not included because JST has not announced the amount of subsidy.
Since JICA does not disclose the budget amount for each year, the total project cost shown in the evaluation at the end of each project or the preliminary evaluation report is divided equally by the project period (months) and allocated to each year. .. In addition, the total project cost shown in the preliminary evaluation report is an approximate amount and may differ from the actual amount.
AMED and JICA operation and management costs are not included.
Government Contribution to Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN)
ESPEN is a project under the jurisdiction of the WHO Africa Regional Office, supporting NTDs mass dosing programs in 52 African countries. The Government of Japan has contributed to ESPEN since 2019 and has included this.
